Tissue factor pathway inhibitor expression in atherosclerosis

Laboratory Investigation

Volumn 77, Issue 4, 1997, Pages 291-298

  Drew, Angela F ^b   Davenport, Piers ^b   Apostolopoulos, Jim ^b   Tipping, Peter G ^a  

^a MONASH UNIVERSITY   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TISSUE FACTOR PATHWAY INHIBITOR;

ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY DISEASE; CAROTID ENDARTERECTOMY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; IN SITU HYBRIDIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RABBIT; RNA ANALYSIS; TISSUE DISTRIBUTION;

AGED; AGED, 80 AND OVER; ANIMALS; AORTA; ARTERIES; ARTERIOSCLEROSIS; ENDOTHELIUM, VASCULAR; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIPOPROTEINS; MALE; MICROCIRCULATION; MIDDLE AGED; RABBITS; RNA, MESSENGER; THROMBOPLASTIN;

EID: 0030694502     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Ameri A, Kuppuswamy MN, Basu S, and Bajaj SP (1992). Expression of tissue factor pathway inhibitor by cultured endothelial cells in response to inflammatory mediators. Blood 79:3219-3226.
2. Bajaj MS, Kuppuswamy MN, Leingang K, and Bajaj SP (1993). Transcriptional expression of tissue factor pathway inhibitor in normal human tissues (abstract). Blood 82(Suppl 1):271A.
3. Bajaj MS, Kuppuswamy MN, Saito H, Spitzer SG, and Bajaj SP (1990). Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: Evidence that endothelium is the principal site of its synthesis. Proc Natl Acad Sci USA 87:8869-8873.
4. Belaaoujaj A, Kuppuswamy MN, Birktoft JJ, and Bajaj SP (1993). Revised cDNA sequence of rabbit tissue factor pathway inhibitor. Thromb Res 69:547-553.
5. Bregengard C, Nordfang O, Wildgoose P, Svendsen O, Hedner U, and Diness V (1993). The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits. Blood Coagul Fibrinolysis 4:699-706.
6. Brinkmann T, Kahnert H, Prohaska W, Nordfang O, and Kleesiek K (1994). Synthesis of tissue factor pathway inhibitor in human synovial cells and chondrocytes makes joints the predilected site of bleeding in haemophiliacs. Eur J Clin Chem Clin Biochem 32:313-317.
7. Creasey AA, Chang AC, Feigen L, Wun T-C, Taylor FB, and Hinshaw LB (1993). Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest 91:2850-2856.
8. Day KC, Hoffman LC, Palmier MO, Kretzmer KK, MD, Pyla EY, Spokas E, Broze GJ, Warren TG, and Wun T-C (1990). Recombinant lipoprotein-associated coagulation inhibitor inhibits tissue thromboplastin-induced intravascular coagulation in the rabbit. Blood 76:1538-1545.
9. Drew AF and Tipping PG (1995). T helper cell infiltration and foam cell proliferation are early events in the development of atherosclerosis in cholesterol-fed rabbits. Arterioscler Thromb Vase Biol 15:1563-1568.
10. Erlich J, Apostolopoulos J, Wun T, Kretzmer KK, Holdsworth SR, and Tipping PG (1996). Renal expression of tissue factor pathway inhibitor and evidence for a role in crescentic glomerulonephritis in rabbits. J Clin Invest 98:325-335.
11. Girard TJ, Warren LA, Novotny WF, Bejcek BE, Miletich JP, and Broze Jr GJ (1989). Identification of the 1.4 kb and 4.0 kb messages for the lipoprotein associated coagulation inhibitor and expression of the encoded protein. Thromb Res 55:37-50.
12. Hansen JB, Huseby NE, Sandset PM, Svensson B, Lyngmo V, and Nordoy A (1994). Tissue-factor pathway inhibitor and lipoproteins. Evidence for association with and regulation by LDL in human plasma. Arterioscler Thromb 14:223-229.
13. Jang Y, Guzman LA, Lincoff AM, Gottsauner-Wolf M, Forudi F, Hart CE, Courtman DW, Ezban M, Ellis SG, and Topol EJ (1995). Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral artery injury model. Circulation 92:3041-3050.
14. Lindhout T, Blezer R, Schloen P, Nordfang O, Reutelingsperger C, and Hemker HC (1992). Activation of factor X and its regulation by tissue factor pathway inhibitor in small-diameter capillaries lined with human endothelial cells. Blood 79:2909-2916.
15. McGee MP, Foster S, and Wang X (1994). Simultaneous expression of tissue factor and tissue factor pathway inhibitor by human monocytes: A potential mechanism for localized control of blood coagulation. J Exp Med 179:1847-1854.
16. Novotny WF, Girard TJ, Miletich JP, and Broze Jr GJ (1988). Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor. Blood 72:2020-2025.
17. Osterud B, Bajaj MS, and Bajaj SP (1995). Sites of tissue factor pathway inhibitor (TFPI) and tissue factor expression under physiologic and pathologic conditions. Thromb Haemost 73:873-875.
18. Sandset PM and Abildgaard U (1991). Extrinsic pathway inhibitor: The key to feedback control of blood coagulation initiated by tissue thromboplastin. Haemostasis 21:219-239.
19. Tipping PG, Malliaros J, and Holdsworth SR (1989). Procoagulant activity expression by macrophages from atheromatous vascular plaques. Atherosclerosis 79:237-243.
20. Tipping PG, Erlich J, Apostolopoulos J, Mackman N, Loskutoff DJ, and Holdsworth SR (1995). Glomerular tissue factor expression: Correlations between antigen, activity and mRNA in crescentic glomerulonephritis in rabbits. Am J Pathol 147:1736-1748.
21. Tsukada T, Rosenfeld ME, Ross R, and Gown AM (1986). Immunocytochemical analysis of cellular components in atherosclerotic lesions: Use of monoclonal antibodies with the Watanabe and fat-fed rabbit. Arteriosclerosis 6:601-613.
22. Warn-Cramer BJ and Maki SL (1992). Purification of tissue factor pathway inhibitor (TFPI) from rabbit plasma and characterization of its differences from TFPI isolated from human plasma. Thromb Res 67:367-383.
23. Warn-Cramer BJ and Rapaport SI (1993). Studies of factorXa/phospholipid-induced intravascular coagulation in rabbits: Effects of immunodepletion of tissue factor pathway inhibitor. Arterioscler Thromb 13:1551-1557.
24. Werling RW, Zacharski LR, Kisiel W, Bajaj SP, Memoli VA, and Rousseau SM (1993). Distribution of tissue factor pathway inhibitor in normal and malignant human tissues. Thromb Haemost 69:366-369.
25. Wilcox JN, Smith KM, Schwartz SM, and Gordon D (1989). Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 86:2839-2843.